
Dimethyl methylphosphonate | CAS:756-79-6
Dimethyl methylphosphonate
- 名称:甲基膦酸二甲酯 | Dimethyl methylphosphonate
- CAS号:756-79-6
- 别名:Dimethyl methanephosphonate; DMMP
- 分子式:C3H9O3P
- 分子量:124.08
- EINESC号:212-052-3
产品描述
物理化学性质
水溶性 | >=10 g/100 mL at 21 ºC |
---|---|
沸点 | 181 ºC |
闪点 | 156 ºF |
密度 | 1.145 |
折射率 | 1.413 |
安全数据
危险品标志 | T |
---|---|
危险类别码 | R36;R46 |
安全说明书 | S53;S26;S45 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Improvement in QTc prolongation induced by zotepine following a switch to perospirone.Yutaro Suzuki et al.Psychiatry and clinical neurosciences, 66(3), 244-244 (2012-03-27)
[The biochemical effect profile of zotepine in comparison with other neuroleptics].M Ackenheil Fortschritte der Neurologie-Psychiatrie, 59 Suppl 1, 2-9 (1991-09-01)
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine DDavid A Sykes et al.Nature communications, 8(1), 763-763 (2017-10-04)
Zotepine-induced spontaneous ejaculation.P-W Wang et al.International journal of clinical pharmacology and therapeutics, 46(11), 571-573 (2008-11-13)
Application of on-line electrochemistry/electrospray/tandem mass spectrometry to a quantification method for the antipsychotic drug zotepine in human serum.Kazuyoshi Nozaki et al.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 25(10), 1197-1201 (2009-10-14)
Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication.Pavel Sistik et al.Biomedical chromatography : BMC, 30(2), 217-224 (2015-06-23)
Clozapine versus other atypical antipsychotics for schizophrenia.Claudia Asenjo Lobos et al.The Cochrane database of systematic reviews, (11)(11), CD006633-CD006633 (2010-11-12)
Zotepine for schizophrenia.M Fenton et al.The Cochrane database of systematic reviews, (2)(2), CD001948-CD001948 (2000-05-05)
Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study.Hsue-Wei Chan et al.Psychiatry and clinical neurosciences, 69(8), 497-503 (2015-03-18)
Safety evaluation of zotepine for the treatment of schizophrenia.Michael Riedel et al.Expert opinion on drug safety, 9(4), 659-666 (2010-05-22)
Systematic development of design of experiments (DoE) optimised self-microemulsifying drug delivery system of Zotepine.Hitesh Dalvadi et al.Journal of microencapsulation, 34(3), 308-318 (2017-04-30)
Antipsychotics for treatment of delirium in hospitalised non-ICU patients.Lisa Burry et al.The Cochrane database of systematic reviews, 6, CD005594-CD005594 (2018-06-20)
Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.Ming-Shang Pai et al.Psychiatry and clinical neurosciences, 66(6), 538-538 (2012-10-17)
A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.Wan-Chih Hsu et al.Journal of clinical psychopharmacology, 31(5), 667-669 (2011-09-02)
Valproate and high dosage of zotepine induced acute delirium: a case report.Wen-Yu Hsu et al.British journal of clinical pharmacology, 73(3), 486-488 (2011-10-13)
Optimizing the early prediction model for symptomatic remission with short-term treatment for schizophrenia.Ching-Hua Lin et al.Journal of clinical psychopharmacology, 32(6), 773-777 (2012-11-08)
Zotepine versus other atypical antipsychotics for schizophrenia.Katja Komossa et al.The Cochrane database of systematic reviews, (1)(1), CD006628-CD006628 (2010-01-22)
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine.Kanako Terakado Kimura et al.Nature structural & molecular biology, 26(2), 121-128 (2019-02-07)
Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.S Yamamura et al.British journal of pharmacology, 157(4), 656-665 (2009-04-18)
Inhibition of Recombinant Human Acetylcholinesterase Activity by Antipsychotics.Keisuke Obara et al.Pharmacology, 104(1-2), 43-50 (2019-05-09)
Zotepine for schizophrenia.P DeSilva et al.The Cochrane database of systematic reviews, (4)(4), CD001948-CD001948 (2006-10-21)
Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.Chao-Cheng Lin et al.Journal of clinical psychopharmacology, 33(2), 211-214 (2013-02-21)
Zotepine versus other atypical antipsychotics for schizophrenia.Selvizhi Subramanian et al.The Cochrane database of systematic reviews, (10)(10), CD006628-CD006628 (2010-10-12)
Zotepine-induced QTc prolongation.Yu-Chung Lin et al.Journal of clinical psychopharmacology, 28(5), 576-578 (2008-09-17)
Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.K Hashimoto et al.Schizophrenia research, 87(1-3), 332-333 (2006-06-27)
Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine.Ching-Hua Lin et al.The Journal of clinical psychiatry, 68(10), 1522-1527 (2007-10-27)
Zotepine-related myopathy in a patient with schizophrenia.I-Ming Chen et al.European journal of clinical pharmacology, 69(3), 725-726 (2012-07-17)
Treatment of clozapine-associated tardive dyskinesia.Chao-Cheng Lin et al.Progress in neuro-psychopharmacology & biological psychiatry, 32(2), 599-600 (2007-10-09)
Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.Wei-Lieh Huang et al.Psychiatry and clinical neurosciences, 66(3), 245-245 (2012-03-27)
A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.Hung-Yu Chan et al.Psychiatry and clinical neurosciences, 64(2), 162-169 (2010-05-08)
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.Jaromír Svestka et al.Neuro endocrinology letters, 28(6), 881-888 (2007-12-08)
Schizophrenia.Stephen Lawrie et al.Clinical evidence, (14)(14), 1306-1330 (2006-04-20)
Zotepine: a clinical review.Ben Green Expert opinion on drug metabolism & toxicology, 5(2), 181-186 (2009-02-10)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!